Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human LILRA2/CD85h/ILT1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB6364
This item is not returnable.
View return policy
Description
ILT1/CD85h/LILRA2 Monoclonal specifically detects ILT1/CD85h/LILRA2 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
ILT1/CD85h/LILRA2 | |
Monoclonal | |
LYOPH | |
Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
Q8N149 | |
LILRA2 | |
Mouse myeloma cell line NS0-derived recombinant human LILRA2/CD85h/ILT1 Pro17-Ser437 Accession # Q8N149 | |
100 μg | |
Primary | |
Detects human LILRA2/CD85h/ILT1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) ILT2, 3, 4, 5, rhLIR6, or rhLIR8 is observed. | |
Human | |
Purified |
Flow Cytometry, CyTOF | |
600007 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD85 antigen-like family member H, CD85h, CD85h antigen, ILT1, ILT-1, ILT1CD85H, Leukocyte immunoglobulin-like receptor 7, leukocyte immunoglobulin-like receptor subfamily A member 2, leukocyte immunoglobulin-like receptor subfamily A member 2 soluble, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2, LIR7, LIR7LIR-7Immunoglobulin-like transcript 1 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
11027 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction